feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Hindustan Zinc share rally

trending

ICICI Bank stock performance

trending

HDFC Bank stock live updates

trending

Natco Pharma share price rises

trending

Paytm share price rallies

trending

IPL auction: 1355 players register

trending

Bangladesh wins T20I series

trending

AIIMS: effects of sleep deprivation

trending

Vivo X300 series launched

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Duolingo's Fair Value Dips, Analysts Adjust Outlook

Duolingo's Fair Value Dips, Analysts Adjust Outlook

2 Dec

•

Summary

  • Duolingo's stock fair value estimate decreased by 6%.
  • Analysts slightly increased discount rate and lowered revenue growth.
  • Several firms maintain positive ratings despite valuation concerns.
Duolingo's Fair Value Dips, Analysts Adjust Outlook

Duolingo's stock valuation has recently been adjusted, with its fair value estimate seeing a decrease of about 6 percent. Analysts have also introduced subtle shifts in their financial models, including a slight uptick in the discount rate and a marginal reduction in projected revenue growth. These recalibrations reflect evolving perspectives on the company's future risk and expansion potential.

Despite these changes, a notable segment of Wall Street analysts maintains a bullish stance. Firms such as Scotiabank, Citi, Needham, and UBS have upheld positive ratings, citing Duolingo's consistent operational excellence and strong quarterly performances. Some analysts even view the recent post-earnings market reaction as a favorable entry point for new investors.

However, reservations regarding valuation persist among even the optimistic analysts. Price targets from institutions like UBS, Scotiabank, and Citi have been substantially lowered, indicating that previous upside potential is now more fully reflected in the current share price. Management's strategic focus on long-term growth over immediate monetization is recognized, yet concerns about overall valuation remain.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Duolingo's stock fair value estimate has decreased due to analysts adjusting their revenue growth expectations and discount rates, signaling a more cautious view on future risk.
Yes, several firms maintain positive or Buy ratings, seeing recent price drops as a buying opportunity, while acknowledging valuation concerns.
Key reservations among analysts revolve around the stock's current valuation, with some price targets being significantly lowered.

Read more news on

Business and Economyside-arrow

You may also like

Nestlé's Target Price Edges Up Amid Mixed Analyst Views

29 Nov • 14 reads

article image

Nokia Stock Soars on AI Hopes & Analyst Upgrades

25 Nov • 26 reads

article image

Wall Street Bullish on Constellation Energy

25 Nov • 18 reads

article image

Banks Unveil Exciting Festive Offers: EMI-Linked Purchases, UPI Credit, and Weekend Discounts

17 Nov • 38 reads

article image

Gilead Sciences Shines as Dividend Champ Amid Biopharma Slump

17 Nov • 59 reads

article image